NCT04654078

Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

An Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To evaluate the pharmacokinetic characteristics and safety of IN-C004 in healthy volunteers

Detailed description

An Open-label, Randomized, Single-dose, Crossover Study

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	IN-C004 with water	One time dose of IN-C004 taken with water
DRUG	IN-C004 without water	One time dose of IN-C004 taken without water
DRUG	K-CAB tab. with water	One time dose of K-CAB tab. taken with water

Timeline

• Start date: 2021-01-18
• Primary completion: 2021-02-05
• Completion: 2021-02-15
• First posted: 2020-12-04
• Last updated: 2021-03-29

Locations

1 site across 1 country: South Korea